On the stock market since 2017, it operates in the world of health and science. It has 1,599 employees. Now — the numbers.
This is an established company with proven profits.
Average growth of 40% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $4.4B would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
The net profit margin is 31% — that slice of every sale is the company’s cushion in hard quarters.
Over the last 3 years, sales grew about 116% a year on average.
There is $4.4B in the vault; even if every debt were paid off, $4.4B would remain.
The company’s market value is 34 times its annual profit. Even a small disappointment could hit the price hard.
On our five-subject report card, ARGX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: ARGX is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.